Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
 
Pharma MNCs are on the Defensive. Are They Thinking Clearly?
Damjan DeNoble, Partner with Rubicon Strategy Group, examines different MNC strategies in the aftermath of China pushing through the first round of national drug price ne... (6/21/2016)
   
China's Bid To Be A DNA Superpower (6/22/2016)
Pharma MNCs are on the Defensive. Are They Thinking Clearly? (6/21/2016)
China Announces A Detailed Pilot Plan For MAH System For Drugs in Selected Regions (6/17/2016)
Chinas Life Sciences Quandary (6/15/2016)
Enforcement Campaign Against Healthcare Companies Signals Evolving Approach to NDRC Investigations (6/13/2016)
China's Policy Environment - Local, Local, Local (6/9/2016)
Cross-Sector Collaboration to Enhance Market Access for Pharmaceutical Companies in Asia: Six Steps to Make It Work (6/8/2016)
China's $9.2B Precision Medicine Initiative could See 100M or More Whole Human Genomes Sequenced by 2030 (6/7/2016)
Sustainably Affordable Health Care in China (6/6/2016)
Pharma Distribution Sector Faces Revolutionary Changes As Government Concludes First Round of National Drug Price Negotiation (6/3/2016)
Novartis CEO on Why the Firm Just Opened a Major R&D Facility in China (6/2/2016)
Pharmaceuticals: China Wishes to Transform Into a Hub for Innovation - Is it Possible? (6/2/2016)
China's Health Consumers Are Hard to Pin Down (5/26/2016) (free)
China's War On Big Pharma Exposes The Mirage Of Market Access (5/25/2016)
China's Drugs Watchdog Struggles as Senior Staff Lured Away By Industry (5/23/2016)
Another Senior Health Official Prosecute...  (6/28/2016)
Health Care: China's Innovation Hotbed  (6/27/2016)
Sanofi, Boehringer Ingelheim Agree to Sw...  (6/27/2016)
Pfizer Breaks Ground on $350M Global Bio...  (6/27/2016)
Uni-Bio Taps Zizhu Pharma for China Sale...  (6/27/2016)
China Resources Pharma to Launch IPO in ...  (6/27/2016)
Tianjin Introduces Maximum BMI Payment S...  (6/27/2016)
CFDA Publishes Pharma Wholsaler Self-Ins...  (6/27/2016) (free)
State Council Issues New Policy for Heal...  (6/27/2016)
Upcoming Event: Pharma Business Developm...  (6/23/2016) (free)
Hengrui Therapeutics Gets $100 Mln Inves...  (6/23/2016)
Recent Executive Moves  (6/23/2016)
Ali Health's Losses More Than Doubled La...  (6/23/2016)
Chi-Med Global Phase II Trial for Savoli...  (6/22/2016)
Ascletis Reports Positive Data from Phas...  (6/22/2016)
Sanofi, Boehringer Ingelheim Agree to Swap Business Asse...
Novartis Splits Pharmaceuticals Division Into Two Busine...
IMS Health Holdings and Quintiles to Combine
Pfizer Abandons Plans to Take Over Allergan Citing New U...
Top 15 Pharma MNCs Experienced Stagnant Performance in 2...
Data Snapshot: Chinese Hospital Ophthalmology Drug Market 2015
Chinee Animal Vaccine Market Estimated To Have Grown 20.9% in 2...
New Study: Cancer Drugs Least Affordable in India and China
Performance of Leading TCs at Level 2 and 3 Hospitals in 2015
CPA: Review of Chinese Hospital Drug Market 2015
Pfizer Breaks Ground on $350M Global Biotech Center in Hangz...
Uni-Bio Taps Zizhu Pharma for China Sales of Ophthalmic Drug...
China Resources Pharma to Launch IPO in Hongkong
Hengrui Therapeutics Gets $100 Mln Investment from HR Bio Ho...
Ali Health's Losses More Than Doubled Last Year Amid Regulat...
CFDA Publishes Pharma Wholsaler Self-Inspection Outcome
CFDA Vice Minister Wu Zhen Meets German and U.S. Regulat...
Jiangsu Mulls New Regulation to Control Drug Prices
CFDA, NHFPC Issues Notice for Implementation of New Vacc...
CFDA Announces 14 Drug Approvals in May 2016
China's Supreme Court Sides with Local Company in Eli Lilly ...
State Council Introduces New Guidelines for Fair Competition...
China Leads Global Pharma Innovation? By Number of Patent Ap...
USTR Singles Out China's Pharma IP Flaws in 2016 Special 301...
More Details Surface for the Recent GSK Trade Secret Theft C...
UK Regenerative Medicine Supplier Expands to China Thru ...
FDA Issues More Warnings Against Chinese API Producers
Dong-A ST Signs Exclusive Deal with Suzhou Sino for Teri...
French Inspectors Uncover Irregularities of Chinese Crud...
Zhejiang Jiuzhou Enters API Supply Agreement with Novart...
Health Care: China's Innovation Hotbed
Chi-Med Global Phase II Trial for Savolitinib
Ascletis Reports Positive Data from Phase II Study for I...
Galmed Pharma Expands Ongoing Phase IIb ARREST Study to ...
TCM Compound Found to Prevent Lung Fibrosis in Mice
Tianjin Introduces Maximum BMI Payment Standards
State Council Issues New Policy for Healthcare Big Data ...
China Pledges Universal Healthcare for the Poor
NHFPC and SATCM Urges Local Governments for Healthcare C...
NHFPC Holds National Drug Administration Conference, Hig...
Another Senior Health Official Prosecuted
Recent Executive Moves
Former NDRC Price Official Prosecuted for Corruption, Impl...
Senior Anhui Health Official Investigated for Corruption
Recent Executive Moves
Upcoming Event: Pharma Business Development Course
Upcoming Event: Pharma Business Development Course
Upcoming Event: Global Pharmaceutical Industry Summit
Upcoming Event: Biopharma Development & Production A...
Upcoming Event: 3rd Annual Med Device Asia 2016
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
  WiCON and PharmaGuys Launch Ph...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Its...
  WiCON Publishes China Pharmace...
  WiCON officially publishes Chi...
© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links